Childhood Leukemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
The functions of EVI1/MEL1 members as transcription factors and the concept of EVI1-positive leukemia as a stem cell disease are also reviewed.
|
17483069 |
2007 |
Childhood Leukemia
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
In contrast, EVI-1 is barely expressed in normal hematopoietic cells, but it is overexpressed in chronic myelocytic leukemia in blastic crisis and myelodysplastic syndrome-derived leukemia.
|
15156182 |
2004 |
Childhood Leukemia
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
These results establish the mechanistic basis underlying the pathogenesis of a severe form of leukemia through aberrant expression of the EVI1 proto-oncogene.
|
24703906 |
2014 |
Childhood Leukemia
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
These results suggest that EVI1 overexpression was the major factor contributing to leukemogenesis, and the late appearance of the Ph chromosome is closely associated with the progression to an aggressive form of leukemia.
|
18206536 |
2008 |
Childhood Leukemia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Although it is unlikely that the Rb gene is directly involved in this translocation, the loss of the Rb gene product combined with the activation of the EVI1 gene may have led to the development of leukemia.
|
8813093 |
1996 |
Childhood Leukemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
In this review, the clinical implications of expression of the GATA family, SCL, and EVI1 gene in various types of human leukemia are discussed.
|
9031072 |
1996 |
Childhood Leukemia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
There is no evidence of ongoing in vivo clonal expansion of the Mds1/Evi1 populations, and all animals are hematologically normal without evidence for leukemia.
|
15933056 |
2005 |
Childhood Leukemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
EVI-1 (ecotropic virus integration site-1) was at first identified as an integration site of the murine leukemia retrovirus in murine myeloid leukemias.
|
10867128 |
2000 |
Childhood Leukemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
VPA may be a promising choice in the molecular targeting therapy of RUNX1-Evi-1-related leukemia.
|
26674644 |
2015 |
Childhood Leukemia
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
High EVI1 expression was detected mainly in myelomonocytic-lineage (designated as e-M4/M5 subtype) leukemia with MLL rearrangements and in megakaryocytic-lineage (designated as e-M7 subtype) leukemia, and its prognostic association was observed in the e-M4/M5 subtype but not in the e-M7 subtype.
|
25567132 |
2015 |
Childhood Leukemia
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
However, aberrantly high expression of EVI1 has potent oncogenic properties and confers poor prognosis and chemo-resistance in leukemia and solid tumors.
|
29939287 |
2018 |
Childhood Leukemia
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Forced expression of the leukemia-associated gene EVI1 in ES cells: a model for myeloid leukemia with 3q26 rearrangements.
|
10557037 |
1999 |
Childhood Leukemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Using the Evi1(pos) MLL-AF9 mouse leukemia model, we demonstrate increased sensitivity to chemotherapeutic agents on reduction of Evi1 expression.
|
22553314 |
2012 |
Childhood Leukemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
The PTEN/AKT/mTOR signaling pathway and the Evi1-polycomb interaction can be promising therapeutic targets for leukemia with activated Evi1.
|
21289308 |
2011 |
Childhood Leukemia
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Overexpression of EVI-1 also occurs with high frequency in leukemia patients without 3q26 abnormalities, and importantly, high EVI-1 expression is an independent negative prognostic indicator irrespective of the presence of 3q26 rearrangements.
|
19385966 |
2009 |
Childhood Leukemia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The AML1-EVI-1 fusion transcript was consistent in all three cases of the t(3;21)-carrying leukemia examined by RNA-based PCR.
|
8313895 |
1994 |
Childhood Leukemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
To identify a metabolic inhibitor for EVI1-induced metabolic reprogramming in MLL-r AML, we used an XFp extracellular flux analyzer to examine metabolic changes during leukemia development in mouse models of AML expressing MLL-AF9 and Evi1 (Evi1/MF9).
|
31649131 |
2019 |
Childhood Leukemia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In this paper, we have analyzed chromosomal rearrangements in two leukemia cell lines derived from CML-BC with inv(3)(q21q26) and have identified the breakpoints within the EVI1 coding area.
|
9192861 |
1997 |
Childhood Leukemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Here, we review the current understanding of the role of Evi1 in controlling the development of leukemia and highlight potential modalities for targeting factors involved in Evi1-regulated signaling.
|
21795762 |
2011 |
Childhood Leukemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Evi-1 is a transforming gene originally identified in a common integration site of murine leukemia retrovirus and mapped in human chromosome 3q26.
|
8656673 |
1996 |
Childhood Leukemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
We propose that rearrangements at 3q26 involving EVI1 could result in leukemia by a two-step process involving first transcriptional disruption of MDS1/EVI1, and next by inappropriately activating expression of EVI1.
|
9067573 |
1997 |
Childhood Leukemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Specific gene activation (N-myc, evi-1) or fusion genes such as the alpha retinoic acid receptor (alpha RAR) and pml have been identified as the specific cause of some cases of leukemia.
|
1434816 |
1992 |
Childhood Leukemia
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Our results suggest that the leukemogenic role of EVI1 expression may differ between post-MDS AML and leukemia, with EVI1 expression associated with a 3q26 abnormality.
|
7780155 |
1995 |
Childhood Leukemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia.
|
24703711 |
2014 |
Childhood Leukemia
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Histone deacetyltransferase could be a target in molecular therapy of RUNX1-EVI1-expressing leukemia.
|
19016745 |
2008 |